Neurological Disorder Diagnostics Market By Disorder Type (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies), By Technology Type (Imaging, In Vitro Diagnostics), Industry Analysis, Trends, and Forecast 2019 – 2025

Report ID: BMRC 249 | Number of pages: 200 | Publish Date: May 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Neurological Disorder Diagnostics Market is valued around USD 11305.69 Million in 2018 and expected to reach USD 18273.57 Million by 2025 with the CAGR of 7.1% over the forecast period. Increased prevalence of neurological disorders and increase in technological advancements are the key drivers for Global Neurological Disorder Diagnostics Market.

Neurological disorder diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about neurological disorder diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with disorder type, technology type, end user.

Neurological disorder diagnostics are the various medical devices used for the diagnosis of various neurological disorders such as Parkinson’s disease, Alzheimer’s disease and others. These medical devices include various imaging devices such as CT Scan, Magnetic resonance Imaging, biopsy and others.  Increasing prevalence of these disorders has led to the increased demand for better diagnostics and better treatment over the period of time.

There are various factors driving the growth of the neurological disorder diagnostics market, one of the major factors expected to drive the growth of this market is increase in the prevalence of neurological disorders and others coupled with increased awareness among people over the period of time. As per Alzheimer’s Association 2018 report, there were around 5.7million of Americans living with Alzheimer’s dementia in 2018 which includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s. Furthermore, various collaborations among major market players are also expected to promote the growth of neurological disorder diagnostics over the forecast period. Moreover, increase in various technological advancements for the development of novel diagnostics are anticipated to fuel drive the growth of market. However, high costs of these medical devices are expected to hinder the growth of neurological disorder diagnostics market.
Global neurological disorder diagnostics market report covers prominent players like Koninklijke Philips N.V., Masimo Corporation, York Instruments Ltd., Esaote SpA, Neusoft Medical Systems, NeuroLogica Corporation, General Electric Company, Canon Medical Systems Corporation and others.

Neurological Disorder Diagnostics Market Segmentation –
By Disorder Type

Genetic Neurological Disorders
Immunological Neurological Disorders
Paraneoplastic Syndrome
Paraproteinemic Neuropathies
Others
By Technology Type 

Imaging
In Vitro Diagnostics
By End-User 

Hospitals
Ambulatory Surgical Centers
Diagnostics Centers
Others
By Region

North America
U.S.
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Neurological Disorder Diagnostics Market is valued around USD 11305.69 Million in 2018 and expected to reach USD 18273.57 Million by 2025 with the CAGR of 7.1% over the forecast period. Increased prevalence of neurological disorders and increase in technological advancements are the key drivers for Global Neurological Disorder Diagnostics Market.

Neurological disorder diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about neurological disorder diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with disorder type, technology type, end user.

Neurological disorder diagnostics are the various medical devices used for the diagnosis of various neurological disorders such as Parkinson’s disease, Alzheimer’s disease and others. These medical devices include various imaging devices such as CT Scan, Magnetic resonance Imaging, biopsy and others.  Increasing prevalence of these disorders has led to the increased demand for better diagnostics and better treatment over the period of time.

Neurological Disorder Diagnostics Market Analysis

There are various factors driving the growth of the neurological disorder diagnostics market, one of the major factors expected to drive the growth of this market is increase in the prevalence of neurological disorders and others coupled with increased awareness among people over the period of time. As per Alzheimer’s Association 2018 report, there were around 5.7million of Americans living with Alzheimer’s dementia in 2018 which includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s. Furthermore, various collaborations among major market players are also expected to promote the growth of neurological disorder diagnostics over the forecast period. Moreover, increase in various technological advancements for the development of novel diagnostics are anticipated to fuel drive the growth of market. However, high costs of these medical devices are expected to hinder the growth of neurological disorder diagnostics market.

 

Neurological Disorder Diagnostics Market Share

Neurological Disorder Diagnostics Market Revenue (USD Million) Analysis by Regional and Global, 2019-2025

Global neurological disorder diagnostics market report covers prominent players like Koninklijke Philips N.V., Masimo Corporation, York Instruments Ltd., Esaote SpA, Neusoft Medical Systems, NeuroLogica Corporation, General Electric Company, Canon Medical Systems Corporation and others.

Neurological Disorder Diagnostics Market Segmentation –
By Disorder Type

Genetic Neurological Disorders
Immunological Neurological Disorders
Paraneoplastic Syndrome
Paraproteinemic Neuropathies
Others
By Technology Type 

Imaging
In Vitro Diagnostics
By End-User 

Hospitals
Ambulatory Surgical Centers
Diagnostics Centers
Others
By Region

North America
U.S.
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Neurological Disorder Diagnostics Market Key Players
Koninklijke Philips N.V.
Masimo Corporation
York Instruments Ltd.
Esaote SpA
Neusoft Medical Systems
NeuroLogica Corporation
General Electric Company
Canon Medical Systems Corporation

1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Neurological Disorder Diagnostics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Neurological Disorder Diagnostics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Neurological Disorder Diagnostics Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Neurological Disorder Diagnostics Market Overview: Quantitative Analysis
3.1. Global Neurological Disorder Diagnostics Market Consumption, Market Share ( %) and Growth Rate, 2015-2025
3.2. Global Neurological Disorder Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015-2025
4. Chapter – Global Neurological Disorder Diagnostics Market Analysis: by Disorder Type
5. Chapter – Global Neurological Disorder Diagnostics Market Analysis: by Technology Type
6. Chapter – Global Neurological Disorder Diagnostics Market Analysis: by End User
7. Chapter – Global Neurological Disorder Diagnostics Market Analysis: by Manufacturer
7.1. Global Neurological Disorder Diagnostics Market Revenue (USD Million), by Manufacturer, 2015-2018
7.2. Global Neurological Disorder Diagnostics Market Consumption, Manufacturer, 2015 – 2018
7.3. Global Neurological Disorder Diagnostics Market Share (%), by Manufacturer, 2018
7.4. Global Neurological Disorder Diagnostics Market Price (USD/Unit), by Manufacturer, 2015-2018
7.5. Global Neurological Disorder Diagnostics Market Revenue Growth Rate (%), by Manufacturer, 2015 – 2018
7.6. Merger & Acquisition
7.7. Collaborations and Partnership
7.8. New Product Launch
8. Chapter – Neurological Disorder Diagnostics Market: Regional Analysis
8.1. North America
8.1.1. North America Neurological Disorder Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2015-2025.
8.1.2. North America Neurological Disorder Diagnostics Market Revenue (USD Million) By Country, 2015-2025.
8.1.3. North America Neurological Disorder Diagnostics Revenue Market Share (%) By Country, 2015-2025.
8.1.4. North America Neurological Disorder Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
8.1.5. North America Neurological Disorder Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
8.1.6. North America Neurological Disorder Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter – Company Profiles
9.1. Koninklijke Philips N.V.
9.1.1. Overview
9.1.2. Financials
9.1.3. Product portfolio
9.1.4. Neurological Disorder Diagnostics Market Revenue (USD Million), Consumption and Market Share (%), 2015 – 2018
9.1.5. Neurological Disorder Diagnostics Sales Market Share (%), 2015 – 2018
9.1.6. Business strategy
9.1.7. Recent developments
9.2. Masimo Corporation
9.3. York Instruments Ltd.
9.4. Esaote SpA
9.5. Neusoft Medical Systems
9.6. NeuroLogica Corporation
9.7. General Electric Company
9.8. Canon Medical Systems Corporation
9.9. Others
10. Chapter – Market Research and Findings
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.